Tower Research Capital LLC (Trc) Pax Medica, Inc. Transaction History

Tower Research Capital LLC (Trc)

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.27 - $0.88 $37 - $122	139 Added 1.79%	7,885 $2,000
Q2 2023 Aug 14, 2023	BUY	$0.76 - $2.08 $2,834 - $7,758	3,730 Added 92.88%	7,746 $6,000
Q1 2023 May 09, 2023	SELL	$1.42 - $3.62 $2,046 - $5,216	-1,441 Reduced 26.41%	4,016 $8,000
Q4 2022 Feb 10, 2023	BUY	$1.4 - $53.55 $5,024 - $192,190	3,589 Added 192.13%	5,457 $11,000
Q3 2022 Nov 10, 2022	BUY	$2.25 - $43.69 $4,203 - $81,612	1,868 New	1,868 $4,000

Ticker PXMD
Exchange
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,779,500
Market Cap $1.41M
Description
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, my...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.